Issue 1/2018
Content (18 Articles)
The newly proposed clinical and post-neoadjuvant treatment staging classifications for gastric adenocarcinoma for the American Joint Committee on Cancer (AJCC) staging
Haejin In, Ethan Ravetch, Marisa Langdon-Embry, Bryan Palis, Jaffer A. Ajani, Wayne L. Hofstetter, David P. Kelsen, Takeshi Sano
Prognostic significance of peritoneal lavage cytology in staging gastric cancer: systematic review and meta-analysis
Sara Jamel, Sheraz R. Markar, George Malietzis, Amish Acharya, Thanos Athanasiou, George B. Hanna
Short-term outcomes in minimally invasive versus open gastrectomy: the differences between East and West. A systematic review of the literature
Nicole van der Wielen, Jennifer Straatman, Miguel A. Cuesta, Freek Daams, Donald L. van der Peet
Tumor-associated macrophage infiltration is highly associated with PD-L1 expression in gastric adenocarcinoma
Kazuto Harada, Xiaochuan Dong, Jeannelyn S. Estrella, Arlene M. Correa, Yan Xu, Wayne L. Hofstetter, Kazuki Sudo, Hisashi Onodera, Koyu Suzuki, Akihiro Suzuki, Randy L. Johnson, Zhenning Wang, Shumei Song, Jaffer A. Ajani
MicroRNA-1 acts as a tumor suppressor microRNA by inhibiting angiogenesis-related growth factors in human gastric cancer
Meng Xie, Dafydd Alwyn Dart, Ting Guo, Xiao-Fang Xing, Xiao-Jing Cheng, Hong Du, Wen G. Jiang, Xian-Zi Wen, Jia-Fu Ji
Importance of human peritoneal mesothelial cells in the progression, fibrosis, and control of gastric cancer: inhibition of growth and fibrosis by tranilast
Hiroto Saito, Sachio Fushida, Shinichi Harada, Tomoharu Miyashita, Katsunobu Oyama, Takahisa Yamaguchi, Tomoya Tsukada, Jun Kinoshita, Hidehiro Tajima, Itasu Ninomiya, Tetsuo Ohta
A prospective multi-institutional validity study to evaluate the accuracy of clinical diagnosis of pathological stage III gastric cancer (JCOG1302A)
Takeo Fukagawa, Hitoshi Katai, Junki Mizusawa, Kenichi Nakamura, Takeshi Sano, Masanori Terashima, Seiji Ito, Takaki Yoshikawa, Norimasa Fukushima, Yasuyuki Kawachi, Takahiro Kinoshita, Yutaka Kimura, Hiroshi Yabusaki, Yasunori Nishida, Yoshiaki Iwasaki, Sang-Woong Lee, Takashi Yasuda, Mitsuru Sasako
Evaluation of the American Joint Committee on Cancer 8th edition staging system for gastric cancer patients after preoperative therapy
Naruhiko Ikoma, Mariela Blum, Jeannelyn S. Estrella, Prajnan Das, Wayne L. Hofstetter, Keith F. Fournier, Paul Mansfield, Jaffer A. Ajani, Brian D. Badgwell
Five-weekly S-1 plus cisplatin therapy combined with trastuzumab therapy in HER2-positive gastric cancer: a phase II trial and biomarker study (WJOG7212G)
Yuji Miura, Yasutaka Sukawa, Shuichi Hironaka, Misuzu Mori, Kazuhiro Nishikawa, Shinya Tokunaga, Hiroyuki Okuda, Takeshi Sakamoto, Keisei Taku, Kazuo Nishikawa, Toshikazu Moriwaki, Yuji Negoro, Yutaka Kimura, Keita Uchino, Katsunori Shinozaki, Hiroharu Shinozaki, Nobuyuki Musha, Hirotsugu Yoshiyama, Takashi Tsuda, Yoshinori Miyata, Naotoshi Sugimoto, Tsuyoshi Shirakawa, Miki Ito, Kimio Yonesaka, Kenichi Yoshimura, Narikazu Boku, Katsuhiko Nosho, Toshimi Takano, Ichinosuke Hyodo
Anthracycline-based triplets do not improve the efficacy of platinum-fluoropyrimidine doublets in first-line treatment of advanced gastric cancer: real-world data from the AGAMEMON National Cancer Registry
A. Carmona-Bayonas, P. Jiménez-Fonseca, A. Custodio, M. Sánchez Cánovas, R. Hernández, C. Pericay, I. Echavarria, A. Lacalle, L. Visa, A. Rodríguez Palomo, M. Mangas, J. M. Cano, E. Buxo, F. Álvarez-Manceñido, T. García, J. E. Lorenzo, M. Ferrer-Cardona, A. Viudez, A. Azkarate, A. Ramchandani, D. Arias, F. Longo, C. López, R. Sánchez Bayona, M. L. Limón, A. Díaz-Serrano, A. Fernández Montes, P. Sala, P. Cerdá, F. Rivera, J. Gallego
Safety, pharmacokinetic, and clinical activity profiles of ramucirumab in combination with three platinum/fluoropyrimidine doublets in Japanese patients with chemotherapy-naïve metastatic gastric/gastroesophageal junction cancer
Kohei Shitara, Shigenori Kadowaki, Tomohiro Nishina, Daisuke Sakai, Reigetsu Yoshikawa, Yongzhe Piao, Akihiro Ozeki, Koichi Inoue, Ismael Gritli, Kei Muro
A non-randomized confirmatory trial of an expanded indication for endoscopic submucosal dissection for intestinal-type gastric cancer (cT1a): the Japan Clinical Oncology Group study (JCOG0607)
Noriaki Hasuike, Hiroyuki Ono, Narikazu Boku, Junki Mizusawa, Kohei Takizawa, Haruhiko Fukuda, Ichiro Oda, Hisashi Doyama, Kazuhiro Kaneko, Shinichiro Hori, Hiroyasu Iishi, Yukinori Kurokawa, Manabu Muto
The value of diagnostic endoscopic submucosal dissection for patients with clinical submucosal invasive early gastric cancer
Keiichi Fujiya, Kohei Takizawa, Masanori Tokunaga, Noboru Kawata, Makoto Hikage, Rie Makuuchi, Yutaka Tanizawa, Etsuro Bando, Taiichi Kawamura, Masaki Tanaka, Naomi Kakushima, Hiroyuki Ono, Masanori Terashima
Long-term outcome of endoscopic submucosal dissection is comparable to that of surgery for early gastric cancer: a propensity-matched analysis
Hye Kyung Jeon, Gwang Ha Kim, Bong Eun Lee, Do Youn Park, Geun Am Song, Dae Hwan Kim, Tae Yong Jeon
Five-year survival analysis of surgically resected gastric cancer cases in Japan: a retrospective analysis of more than 100,000 patients from the nationwide registry of the Japanese Gastric Cancer Association (2001–2007)
Hitoshi Katai, Takashi Ishikawa, Kohei Akazawa, Yoh Isobe, Isao Miyashiro, Ichiro Oda, Shunichi Tsujitani, Hiroyuki Ono, Satoshi Tanabe, Takeo Fukagawa, Souya Nunobe, Yoshihiro Kakeji, Atsushi Nashimoto
Long-term outcomes of laparoscopy-assisted distal gastrectomy with suprapancreatic nodal dissection for clinical stage I gastric cancer: a multicenter phase II trial (JCOG0703)
Naoki Hiki, Hitoshi Katai, Junki Mizusawa, Kenichi Nakamura, Mikihito Nakamori, Takaki Yoshikawa, Kazuyuki Kojima, Haruhiko Imamoto, Motoki Ninomiya, Seigo Kitano, Masanori Terashima
Higher incidence of pancreatic fistula in laparoscopic gastrectomy. Real-world evidence from a nationwide prospective cohort study
Naoki Hiki, Michitaka Honda, Tsuyoshi Etoh, Kazuhiro Yoshida, Yasuhiro Kodera, Yoshihiro Kakeji, Hikaru Kumamaru, Hiroaki Miyata, Yuichi Yamashita, Masafumi Inomata, Hiroyuki Konno, Yasuyuki Seto, Seigo Kitano
The comprehensive complication index (CCI) is a more sensitive complication index than the conventional Clavien–Dindo classification in radical gastric cancer surgery
Tae-Han Kim, Yun-Suhk Suh, Yeon-Ju Huh, Young-Gil Son, Ji-Ho Park, Jun-Young Yang, Seong-Ho Kong, Hye Seong Ahn, Hyuk-Joon Lee, Ksenija Slankamenac, Pierre Alain Clavien, Han-Kwang Yang